{"id":"https://openalex.org/W1444813801","doi":null,"title":"Is Docetaxel Chemotherapy a New Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer?","display_name":"Is Docetaxel Chemotherapy a New Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer?","publication_year":2015,"publication_date":"2015-09-09","ids":{"openalex":"https://openalex.org/W1444813801","mag":"1444813801"},"language":"en","primary_location":{"id":"mag:1444813801","doi":null,"is_oa":false,"landing_page_url":"https://www.gotoper.com/publications/ajho/2015/2015Sep/Is-Docetaxel-Chemotherapy-a-New-Standard-of-Care-for-Metastatic-Hormone-Sensitive-Prostate-Cancer","pdf_url":null,"source":{"id":"https://openalex.org/S4306501600","display_name":"American Journal of Hematology / Oncology\u00ae","issn_l":"1939-6163","issn":["1939-6163"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"American Journal of Hematology / Oncology\u00ae","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059178256","display_name":"Bobby Chi-Hung Liaw","orcid":"https://orcid.org/0000-0003-4371-0267","observed_orcids":["https://orcid.org/0000-0003-4371-0267"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bobby Chi-Hung Liaw","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5078027978","display_name":"William K. Oh","orcid":"https://orcid.org/0000-0001-5113-8147","observed_orcids":["https://orcid.org/0000-0001-5113-8147"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Oh","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5113-8147","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3151,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.53792469,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"11","issue":"9","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9890000224113464},{"id":"https://openalex.org/keywords/metastatic-hormone-sensitive-prostate-cancer","display_name":"metastatic hormone-sensitive prostate cancer","score":0.9909999966621399},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9169999957084656},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.9539999961853027},{"id":"https://openalex.org/keywords/combined-androgen-blockade","display_name":"combined androgen blockade","score":0.7409999966621399},{"id":"https://openalex.org/keywords/intermittent-androgen-deprivation-therapy","display_name":"intermittent androgen deprivation therapy","score":0.7059999704360962},{"id":"https://openalex.org/keywords/timing-of-chemotherapy","display_name":"chemotherapy timing","score":0.5619999766349792},{"id":"https://openalex.org/keywords/standard-of-care","display_name":"standard of care","score":0.8569999933242798}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9616503715515137},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8423870801925659},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6650416254997253},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.6644032001495361},{"id":"https://openalex.org/C2778971682","wikidata":"https://www.wikidata.org/wiki/Q412963","display_name":"Cabazitaxel","level":5,"score":0.6185921430587769},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.5980297923088074},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5839491486549377},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4706674814224243},{"id":"https://openalex.org/C2779322244","wikidata":"https://www.wikidata.org/wiki/Q574820","display_name":"Antiandrogen","level":4,"score":0.4518144726753235},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.4464690089225769},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.43706265091896057},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.42873436212539673},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.42484211921691895},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36221736669540405},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.23392724990844727},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05419635772705078}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1444813801","doi":null,"is_oa":false,"landing_page_url":"https://www.gotoper.com/publications/ajho/2015/2015Sep/Is-Docetaxel-Chemotherapy-a-New-Standard-of-Care-for-Metastatic-Hormone-Sensitive-Prostate-Cancer","pdf_url":null,"source":{"id":"https://openalex.org/S4306501600","display_name":"American Journal of Hematology / Oncology\u00ae","issn_l":"1939-6163","issn":["1939-6163"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"American Journal of Hematology / Oncology\u00ae","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W2003985632","https://openalex.org/W2080439368","https://openalex.org/W2084521917","https://openalex.org/W2114806969","https://openalex.org/W2118200288","https://openalex.org/W2120292596","https://openalex.org/W2142466432","https://openalex.org/W2150865892","https://openalex.org/W2165542862","https://openalex.org/W2168242827","https://openalex.org/W2473766508","https://openalex.org/W2900686362"],"related_works":["https://openalex.org/W2809732130","https://openalex.org/W2524206450","https://openalex.org/W3031371714","https://openalex.org/W2240099744","https://openalex.org/W3088473878","https://openalex.org/W3118893777","https://openalex.org/W2402040409","https://openalex.org/W7133551938","https://openalex.org/W4400173105","https://openalex.org/W2778255532"],"abstract_inverted_index":{"Introduction":[0],"Docetaxel":[1,119],"forever":[2],"changed":[3],"the":[4,14,27,50,103,106,123,127],"treatment":[5,107,129],"landscape":[6],"of":[7,52,71,101,130],"advanced":[8],"prostate":[9,21,66],"cancer":[10,22,67],"when":[11],"it":[12],"demonstrated":[13],"first-ever":[15],"survival":[16],"benefit":[17],"in":[18,42,136],"metastatic":[19,64],"castration-resistant":[20],"(mCRPC).":[23],"Its":[24],"impact":[25],"on":[26],"mCRPC":[28],"frontier":[29],"persists":[30],"to":[31,49,122],"this":[32],"day,":[33],"with":[34],"all":[35],"subsequently":[36],"approved":[37],"CRPC":[38],"agents":[39],"proving":[40],"themselves":[41],"clinical":[43],"arenas":[44],"defined":[45],"by":[46],"their":[47],"relation":[48],"timing":[51],"docetaxel.":[53],"With":[54],"androgen-deprivation":[55],"therapy":[56,62],"(ADT)":[57],"firmly":[58],"established":[59],"as":[60],"first-line":[61],"for":[63,82,109,126],"hormone-sensitive":[65],"(mHSPC),":[68],"multiple":[69],"variations":[70],"suppressing":[72],"androgen":[73,94,104],"production":[74],"and":[75,86,96],"signaling":[76],"have":[77],"been":[78,113],"evaluated.":[79],"Our":[80],"playbook":[81],"HSPC":[83],"has":[84,111],"grown,":[85],"now":[87,125],"includes":[88],"continuous":[89],"ADT,":[90,92],"intermittent":[91],"combined":[93],"blockade,":[95],"antiandrogen":[97],"monotherapy.":[98],"However,":[99],"outside":[100],"disrupting":[102],"pathway,":[105],"paradigm":[108],"mHSPC":[110],"not":[112,132],"significantly":[114],"challenged":[115],"until":[116],"more":[117],"recently.":[118],"again":[120],"returns":[121],"vanguard,":[124],"upfront":[128],"mHSPC\u2014but":[131],"without":[133],"some":[134],"controversy":[135],"tow.":[137]},"counts_by_year":[{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}